Antonella Zannetti

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 20

Top Topics

Mesenchymal Stem Cells

Breast Cancer Cells

Top Venues

International journal of molecular sciences

Journal of experimental & clinical cancer research : CR

This page only lists publications with an associated author ORCID identifier.

Publications

Annachiara Sarnella, Ylenia Ferrara, Sandra Albanese, Daniela Omodei, Gennaro Chiappetta, Giuseppina De Simone, Claudiu T Supuran, Antonella Zannetti
Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells. Cells 12 (2) (2023)
Annachiara Sarnella, Ylenia Ferrara, Sandra Albanese, Daniela Omodei, Gennaro Chiappetta, Giuseppina De Simone, Claudiu T Supuran, Antonella Zannetti
Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells. Cells 12 (2) (2023)
Annachiara Sarnella, Ylenia Ferrara, Sandra Albanese, Daniela Omodei, Gennaro Chiappetta, Giuseppina De Simone, Claudiu T Supuran, Antonella Zannetti
Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells. Cells 12 (2) (2023)
Nancy Nisticò, Annamaria Aloisio, Antonio Lupia, Anna Maria Zimbo, Selena Mimmi, Domenico Maisano, Rossella Russo, Fabiola Marino, Mariangela Scalise, Emanuela Chiarella, Teresa Mancuso, Giuseppe Fiume, Daniela Omodei, Antonella Zannetti, Giuliana Salvatore, Ileana Quinto, Enrico Iaccino
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype. Cells 12 (7) (2023)
Antonella Zannetti
Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0. International journal of molecular sciences 24 (3) (2023)
Antonella Zannetti
Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0. International journal of molecular sciences 24 (3) (2023)
Antonella Zannetti
Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0. International journal of molecular sciences 24 (3) (2023)
Lisa Agnello, Annachiara d'Argenio, Alessandra Caliendo, Roberto Nilo, Antonella Zannetti, Claudio Arra, Simona Camorani, Gennaro Chiappetta
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells. Cells 12 (13) (2023)
Annachiara Sarnella, Ylenia Ferrara, Sandra Albanese, Daniela Omodei, Gennaro Chiappetta, Giuseppina De Simone, Claudiu T Supuran, Antonella Zannetti
Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells. Cells 12 (2) (2023)
Antonella Zannetti
Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0. International journal of molecular sciences 24 (3) (2023)
Simona Camorani, Silvia Tortorella, Lisa Agnello, Chiara Spanu, Annachiara d'Argenio, Roberto Nilo, Antonella Zannetti, Erica Locatelli, Claudio Arra, Mauro Comes Franchini, Gennaro Chiappetta
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells. Pharmaceutics 14 (10) (2022)
Simona Camorani, Annachiara d'Argenio, Lisa Agnello, Roberto Nilo, Antonella Zannetti, Luis Exequiel Ibarra, Claudio Arra, Laura Cerchia
Optimization of Short RNA Aptamers for TNBC Cell Targeting. International journal of molecular sciences 23 (7) (2022)
Annachiara Sarnella, Ylenia Ferrara, Luigi Auletta, Sandra Albanese, Laura Cerchia, Vincenzo Alterio, Giuseppina De Simone, Claudiu T Supuran, Antonella Zannetti
Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Chiara Rosso, Cristina Demelas, Greta Agostini, Maria Lorena Abate, Marta Vernero, Gian Paolo Caviglia, Daphne D'Amato, Angelo Armandi, Marta Tapparo, Marta Guariglia, Giulia Troshina, Alessandro Massano, Antonella Olivero, Aurora Nicolosi, Antonella Zannetti, Rinaldo Pellicano, Alessia Ciancio, Giorgio Maria Saracco, Davide Giuseppe Ribaldone, Elisabetta Bugianesi, Sharmila Fagoonee
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis. Viruses 14 (11) (2022)
Francesca Maria Orlandella, Luigi Auletta, Adelaide Greco, Antonella Zannetti, Giuliana Salvatore
Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review. Cancers 13 (23) (2021)
Annachiara Sarnella, Giuliana D'Avino, Billy Samuel Hill, Vincenzo Alterio, Jean-Yves Winum, Claudiu T Supuran, Giuseppina De Simone, Antonella Zannetti
A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity. International journal of molecular sciences 21 (21) (2020)
Antonella Zannetti, Gheorghe Benga, Arturo Brunetti, Francesco Napolitano, Luigi Avallone, Alessandra Pelagalli
Role of Aquaporins in the Physiological Functions of Mesenchymal Stem Cells. Cells 9 (12) (2020)
Crescenzo D'Alterio, Antonella Zannetti, Anna Maria Trotta, Caterina Ieranò, Maria Napolitano, Giuseppina Rea, Adelaide Greco, Piera Maiolino, Sandra Albanese, Giosuè Scognamiglio, Fabiana Tatangelo, Salvatore Tafuto, Luigi Portella, Sara Santagata, Guglielmo Nasti, Alessandro Ottaiano, Roberto Pacelli, Paolo Delrio, Gerardo Botti, Stefania Scala
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer. Cancers 12 (7) (2020)
Billy Samuel Hill, Annachiara Sarnella, Domenica Capasso, Daniela Comegna, Annarita Del Gatto, Matteo Gramanzini, Sandra Albanese, Alessandro Tossi, Laura Zaccaro, Antonella Zannetti
Therapeutic Potential of a Novel αvβ₃ Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type. Cancers 11 (2) (2019)
Sara Santagata, Luigi Portella, Maria Napolitano, Adelaide Greco, Crescenzo D'Alterio, Maria Vittoria Barone, Antonio Luciano, Matteo Gramanzini, Luigi Auletta, Claudio Arra, Antonella Zannetti, Stefania Scala
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors. Scientific reports 7 (1) (2017)